FDA recall D-0308-2021

Breckenridge Pharmaceutical, Inc · Class II · drug

Product

Omeprazole Delayed-Release Capsules, USP, 20 mg, 1000 count bottles, Rx Only, distributed by Breckenridge Pharmaceutical, Inc., Berlin, CT, Manufactured by Tow Pharmaceutical Europe, S.L., Martorelles (Barcelona), Spain NDC 51991-643-10

Reason for recall

Failed Impurities/Degradation Specifications: Out-of-Specification results obtained for unknown impurities during stability testing.

Distribution

Product was distributed nationwide

Key facts

Status
Terminated
Initiation date
2021-03-11
Report date
2021-03-24
Termination date
2022-03-23
Voluntary/Mandated
Voluntary: Firm initiated
Location
Berlin, CT, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0308-2021